The short answer is: a small number are producing measurable clinical and financial outcomes, but most consumer health apps are still better at engagement than at changing healthcare costs or long-term health.
The strongest evidence tends to come from products that are:
- Connected to a care team rather than being standalone.
- Targeting a specific chronic condition.
- Used continuously for months, not days.
- Reimbursed or integrated into healthcare delivery.
Here's how the evidence looks by category.
| Category | Clinical outcomes | Financial outcomes | Evidence strength |
|---|
| Diabetes CGMs | Very strong | Strong | ★★★★★ |
| Hypertension monitoring | Strong | Moderate-strong | ★★★★☆ |
| Digital diabetes prevention | Moderate | Moderate | ★★★★☆ |
| Cardiac rhythm wearables | Strong for detection | Mixed | ★★★★☆ |
| Sleep apnea monitoring | Moderate | Emerging | ★★★☆☆ |
| Mental health apps | Mixed | Weak-moderate | ★★☆☆☆ |
| Fitness trackers | Small | Weak | ★★☆☆☆ |
| Nutrition apps | Small | Weak | ★★☆☆☆ |
1. Continuous glucose monitors (CGMs)
This is probably the clearest success story.
Examples include devices from:
Clinical outcomes:
- Lower HbA1c
- Fewer hypoglycemic episodes
- Better time-in-range
- Lower diabetes distress
- Improved pregnancy outcomes in diabetes
Financial outcomes:
- Fewer emergency visits
- Reduced hospitalizations
- Lower total cost for insulin-treated populations over time
The savings become most apparent among people with poorly controlled diabetes and those at high risk of complications.
2. Remote blood pressure monitoring
This has become one of the highest ROI digital health interventions.
Common ecosystem:
- Bluetooth cuff
- Mobile app
- Nurse/pharmacist coaching
- Physician oversight
Clinical improvements:
- Higher rates of blood pressure control
- Faster medication titration
- Better medication adherence
Financial impact:
- Reduced stroke risk
- Reduced heart failure admissions
- Lower downstream cardiovascular costs
The technology itself isn't the key—the care workflow is.
3. Diabetes prevention programs
Companies such as:
have demonstrated:
Clinical outcomes:
- Sustained weight loss
- Lower progression from prediabetes to diabetes
- Improved metabolic markers
Financial outcomes:
- Employer healthcare savings
- Reduced diabetes incidence
- Lower long-term treatment costs
These programs work best when they include:
- coaching
- connected scales
- behavior change
- longitudinal engagement
rather than simply tracking food.
4. Smartwatches for cardiac monitoring
Examples:
Clinical benefit:
- Earlier atrial fibrillation detection
- Faster diagnosis
- Earlier anticoagulation when appropriate
Financial picture:
More nuanced.
Benefits:
- Preventing strokes saves substantial costs.
Potential downside:
- Increased diagnostic testing
- False positives
- More cardiology referrals
Overall, these devices appear most cost-effective in older adults or people with elevated cardiovascular risk.
5. Sleep wearables
Examples include:
Evidence shows improvements in:
- sleep awareness
- recovery behaviors
- adherence to healthy routines
However:
- They do not diagnose most sleep disorders.
- Long-term outcome evidence is still limited.
Financial evidence remains modest.
6. Mental health apps
Examples include meditation, CBT, mood tracking, and digital therapy platforms.
Evidence:
- Small-to-moderate reductions in anxiety
- Small improvements in depression symptoms
- Better access to care
Challenges:
- High dropout rates
- Engagement often falls after a few weeks
- Variable study quality
Financial outcomes remain inconsistent.
7. Fitness trackers
Examples:
- Fitbit
- Garmin
- Apple Watch
Consistent findings:
- Increased daily steps
- Increased physical activity
- Short-term weight loss
Less convincing:
- Long-term reduction in cardiovascular events
- Reduced healthcare spending
Most people stop using activity trackers within a year, limiting sustained impact.
What actually predicts success?
Across hundreds of studies, the biggest predictor isn't the sensor—it's the care model.
Successful programs usually combine:
- Passive data collection
- Human coaching
- Medication management
- Physician integration
- Personalized feedback
- Long-term engagement
- Automated alerts for meaningful changes
A smartwatch alone rarely changes outcomes. A smartwatch that triggers medication adjustments or targeted coaching is much more likely to do so.
Financial outcomes: where the ROI is strongest
From a payer or employer perspective, the strongest evidence for positive return on investment is in:
- Diabetes management with CGMs
- Remote hypertension monitoring
- Digital diabetes prevention
- Heart failure remote monitoring (typically with clinical-grade devices rather than consumer wearables)
- Medication adherence and chronic disease management programs
By contrast, general wellness apps and activity trackers often improve engagement and self-awareness but have not consistently demonstrated reductions in total healthcare spending.
Where the field is heading
The next phase is shifting from consumer wellness to clinical decision support. Increasingly, wearables are being used to detect deterioration earlier, personalize treatment, and trigger timely clinical interventions, often enhanced by AI models that analyze continuous streams of physiologic data. The value proposition is becoming less about collecting more data and more about delivering the right intervention at the right time.
For healthcare systems and employers, the most promising products are those that fit into clinical workflows, support reimbursement models, and have demonstrated outcomes in randomized or real-world studies—not simply those with the most sensors or the highest user engagement.
